References
Stringer JR, Beard CB, Miller RF, Wakefield AE (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8:891–890
Sepkowiz KA (2002) Opportunistic infestions in patients with and patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis 34:1098–1107
Roblot F (2005) Management of Pneumocystis pneumonia in patients with inflammatory disorders. Expert Rev Anti Infect Ther 3:435–444
Ward MM, Donald F (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42:780–789
Peters JW, Sattler FR (1983) Atypical Pneumonitis carinii pneumonia: the potential hazards of empric treatment. South Med J 76:800–803
Knight DM, Trinh H, Le J, Siegel S, Shealy D, McDonough M, Scallon B, Moore MA, Vilcek J, Daddona P, Ghrayeb J (1993) Construction and initial characteraization a mouse-human chimeric anti-TNF antibody. Mol Immunol 30:1443–1453
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P, ACCENT I Study Group (2002) Maintenance infliximab for Crohn’s disease: the ACCENT I randomized trial. Lancet 359:1541–1549
Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF (2005) Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 353:2462–2476
Colombel JF, Loftus EV Jr, Tremaine WJ, Pemberton JH, Wolff BG, Young-Fadok T, Harmsen WS, Schleck SD, Sandborn WJ (2004) The safety profile of infliximab in patients with Crohn’s disease: the Mayo clinic experience in 500 patients. Gastroenterology 126:19–31
Sandborn WJ, Hanauer SB (2002) Infliximab in the treatment of Crohn’s disease: a user’s guide for clinician’s. Am J Gastroenterol 97:2962–2972
Seddik M, Meliez H, Seguy D, Viget N, Cortot A, Colombel JF (2004) Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn’s disease. Inflamm Bowel Dis 10:436–437
Velayos FS, Sandborn WJ (2004) Pneumocystisis carinii pneumonia during maintenance anti-tumor necrosis factor-a therapy with infliximab for Crohn’s disease. Inflamm Bowel Dis 10:657–660
Kaur N, Mahl TC (2004) Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn’s disease. Dig Dis Sci 49:1458–1460
Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S (1996) (1→3)Beta-D-glucan as a quantitive serological marker for Pneumocystis pneumonia. Clin Diagn Lab Immunol 3:197–199
Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk. Arch Intern Med 155:1125–1128
Rizzello F, Gionchetti P, Venturi A, Morselli C, Campieri M (2002) Review article: the management of refractory Crohn’s disease. Aliment Pharmacol Ther 16:40–47
Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, Meyer zum Buschenfelde KH (1993) Azathioprine combined with predonisolone or monotherapy with prednisolone in active Crohn’s disease. Gastroenterology 105:367–372
Pearson DC, May GR, Fick GH, Sutherland LR (1995) Azathioprine and 6-mercaptopurine in Crohn’s disease. A meta-analysis. Ann Intern Med 15:132–142
Fraser AG, Orchard TR, Jewell DP (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut 50:485–489
Khatchatourian M, Seaton TL (1997) An unusual complication of immunosuppressive therapy in inflammatory bowel disease. Am J Gastroenterol 92:1558–1560
Cohen RD, Tsang JF, Hanauer SB (2000) Infliximab in Crohn’s disease: first anniversary clinical experience. Am J Gastroenterol 95:3469–3477
Godeau B, Coutant-Perronne V, Le Thi Huong D, Guillevin L, Magadur G, De Bandt M, Dellion S, Rossert J, Rostoker G, Piette JC, Schaeffer A (1994) Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol 21:246–251
Thomas CF Jr, Limper AH (2004) Pneumocystis pneumonia. N Engl J Med 350:2487–2498
Wazir JF, Ansari NA (2004) Pneumocystis carinii infection. Update and review. Arch Pathol Lab Med 128:1023–1027
Targan SR, Hanauer SB, van Deventer SJ, Mayer L, Present DH, Braakman T, DeWoody KL, Schaible TF, Rutgeerts PJ (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. N Engl J Med 337:1029–1035
Pareja JG, Garland R, Kozeil H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215–1224
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Itaba, S., Iwasa, T., Sadamoto, Y. et al. Pneumocystis Pneumonia During Combined Therapy of Infliximab, Corticosteroid, and Azathioprine in a Patient with Crohn’s Disease. Dig Dis Sci 52, 1438–1441 (2007). https://doi.org/10.1007/s10620-006-9575-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9575-5